Pharming Group N.V. (PHAR) Other Non-Current Assets (2019 - 2024)

Pharming (PHAR) has disclosed Other Non-Current Assets for 6 consecutive years, with $1.5 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets changed 0.33% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2024, changed 0.33%, and an annual FY2024 reading of $1.5 million, changed 0.33% over the prior year.
  • Other Non-Current Assets was $1.5 million for Q4 2024 at Pharming, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.5 million in Q4 2024 and bottomed at $494800.3 in Q4 2020.
  • Average Other Non-Current Assets over 5 years is $1.2 million, with a median of $1.3 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets crashed 80.29% in 2020, then surged 102.1% in 2021.
  • Year by year, Other Non-Current Assets stood at $494800.3 in 2020, then soared by 102.1% to $1.0 million in 2021, then soared by 31.2% to $1.3 million in 2022, then grew by 14.33% to $1.5 million in 2023, then rose by 0.33% to $1.5 million in 2024.
  • Business Quant data shows Other Non-Current Assets for PHAR at $1.5 million in Q4 2024, $1.5 million in Q4 2023, and $1.3 million in Q4 2022.